Effect of low dose vitamin K2 (MK-4) supplementation on bio-indices in postmenopausal Japanese women

Journal of Nutritional Science and Vitaminology

Volumn 55, Issue 1, 2009, Pages 15-21

  Koitaya, Noriko ^a   Ezaki, Junko ^a   Nishimuta, Mamoru ^a   Yamauchi, Jun ^a   Hashizume, Erika ^b   Morishita, Koji ^b   Miyachi, Motohiko ^a   Sasaki, Satoshi ^a   Ishimi, Yoshiko ^a  

^a NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

^b KYOWA HAKKO BIO CO   (Japan)

Author keywords

Bone metabolism; Menaquinone 4; Osteocalcin; Postmenopausal women; Serum lipids

Indexed keywords

CHOLESTEROL; CREATININE; ESTRADIOL; FARNOQUINONE; GAMMA CARBOXYLATED OSTEOCALCIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MENATETRENONE; OSTEOCALCIN; PLACEBO; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UNDERCARBOXYLATED OSTEOCALCIN; 25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; BIOLOGICAL MARKER; DRUG DERIVATIVE; LIPID; PHYTOMENADIONE; VITAMIN; VITAMIN D;

ADULT; AGED; ARTICLE; BONE METABOLISM; BONE TURNOVER; CARBOXYLATION; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOUBLE BLIND PROCEDURE; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; JAPANESE; LIPID BLOOD LEVEL; LIPID METABOLISM; MORNING DOSAGE; NORMAL HUMAN; PATIENT COMPLIANCE; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION; BLOOD; BLOOD PRESSURE; BONE; DIET SUPPLEMENTATION; DRUG EFFECT; JAPAN; METABOLISM; MIDDLE AGED; POSTMENOPAUSE OSTEOPOROSIS;

BIOLOGICAL MARKERS; BLOOD PRESSURE; BONE AND BONES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; ESTRADIOL; FEMALE; HUMANS; JAPAN; LIPIDS; MIDDLE AGED; OSTEOCALCIN; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE; VITAMIN D; VITAMIN K 1; VITAMIN K 2; VITAMINS;

EID: 58849133714     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.55.15     Document Type: Article

References (32)

1. Vermeer C. 1990. Gamma-carboxyglutamate-containing proteins and the vitamin-K-dependent carboxylase. Biochem J 266: 62 5-636.
2. Adams J, Pepping J. 2005. Vitamin K in the treatment and prevention of osteoporosis and arterial calcification. Am J Health Syst Pharm 62: 1574-1581.
3. 2) in r1ice: two possible routes for nemaquinone-4 accumulation in cerebra of mice. J Biol Chem 283: 112 70-112 79.
4. 2 in bone metabolism and osteoporosis. Altern Med Rev 10: 24-35.
5. Ministry of Health, Labour, and Welfare, Japan. 2005. Dietary Reference Intakes for Japanese, 2005. Daiichi Shuppan Publishing Co., Ltd., Tokyo (in Japanese).
6. Booth SL, Martini L, Peterson JW, Saltzman E, Dallal GE, Wood RJ. 2003. Dietary phylloquinone depletion and repletion in older women. J Nutr 133: 2565-2569.
7. Kaneki M, Hodges SJ, Hosoi T, Fujiwara S, Lyons A, Crean SJ, Ishida N, Nakagawa M, Takechi M, Sano Y, Mizuno Y, Hoshino S, Miyao M, Inoue S, Horiki K, Shiraki M, Ouchi Y, Orimo H. 2001. Japanese fermented soybean food as the major determinant of the large geographic difference in circulating levels of vitamin K2: possible implications for hip-fracture risk. Nutrition 17: 315-321.
8. Tsugawa N, Shiraki M, Suhara Y, Kamao M, Ozaki R, Tanaka K, Okano T. 2008. Low plasma phylloquinone concentration is associated with high incidence of vertebral fracture in Japanese women. J Bone Miner Metab 26: 79-85.
9. Tsukamoto Y, Ichise H, Kakuda H, Yamaguchi M. 2000. Intake of fermented soybean (natto) increases circulating vitamin K2 (menaquinone-7) and gamma-carboxylated osteocalcin concentration in normal individuals. J Bone Miner Metab 18: 216-222.
10. Schurgers LJ, Teunissen KJ, Hamulyák K, Knapen MH, Vik H, Vermeer C. 200 7. Vitamin K-containing dietary supplements: comparison of synthetic vitamin Kl and natto-derived menaquinone-7. Blood 109: 3279-3283.
11. Ozuru R, Sugimoto T, Yamaguchi T, Chihara K. 2002. Time-dependent effects of vitamin K2 (menatetrenone) on bone metabolism in postmenopausal women. Endocr J 49: 363-370.
12. 3 and estrogen-progestin therapy. Maturitas 31: 161-164.
13. Ishida Y, Kawai S. 2004. Comparative efficacy of hormone replacement therapy, etidronate, calcitonin, alfa-calcidol, and vitamin K in postmenopausal women with osteoporosis: The Yamaguchi Osteoporosis Prevention Study. Am J Med 117: 549-555.
14. Shiraki M, Shiraki Y, Aoki C, Miura M. 2000. Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumber bone mineral density in osteoporosis. J Bone Miner Res 15: 515-521.
15. Sasaki N, Kusano E, Takahashi H, Ando Y, Yano K, Tsuda E, Asano Y. 2005. Vitamin K2 inhibits glucocorticoid-induced bone loss partly by preventing the reduction of osteoprotegerin (OPG). J Bone Miner Metab 23: 41-47.
16. Langenberg JP, Tjaden UR. 1984. Improved method for the determination of vitamin Kl epoxide in human plasma with electrofluorimetric reaction detection. J Chromatogr 289: 377-385.
17. Kagawa Y. 2005. Standard Tables of Food Composition in Japan, 5th revised ed. Kagawa Education Institute of Nutrition, Tokyo (in Japanese).
18. Cockayne S, Adamson J, Lanham-New S, Shearer MJ, Gilbody S, Torgerson DJ. 2006. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch Intern Med 166: 1256-1261.
19. Binkley NC, Krueger DC, Kawahara TN, Engelke JA, Chappell RJ, Suttie JW. 2002. A high phylloquinone intake is required to achieve maximal osteocalcin γ-carboxylation. Am J Clin Nutr 76: 1055-1060.
20. Tsugawa N, Shiraki M, Suhara Y, Kamao M, Tanaka K, Okano T. 2006. Vitamin K status of healthy Japanese women: age-related vitamin K requirement for γ-carboxylation of osteocalcin. Am J Clin Nutr 83: 380-386.
21. 2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women. Osteoporosis Int 18: 963-972.
22. Knapen MH, Nieuwenhuijzen Kruseman AC, Wouters RS, Vermeer C. 1998. Correlation of serum osteocalcin fractions with bone mineral density in women during the first 10 years after menopause. Calcif Tissue Int 63: 375-379.
23. Sokoll LJ, Sadowski JA. 1996. Comparison of biochemical indexes for assessing vitamin K nutritional status in a healthy adult population. Am J Clin Nutr 63: 566-573.
24. Szule P, Chapuy MC, Meunier PJ, Delmas PD. 1993. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 91: 1769-1774.
25. Knapen MH, Jie KS, Hamulyak K, Vermeer C. 1993. Vitamin K-induced changes in markers for osteoblast activity and urinary calcium loss. Calcif Tissue Int 53: 81-85.
26. Szulc P, Arlot M, Chapuy MC, Duboeuf F, Meunier PJ, Delmas PD. 1994. Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women. J Bone Miner Res 9: 1591-1595.
27. Takahashi M, Naitou K, Ohishi T, Kushida K, Miura M. 2001. Effect of vitamin K and/or D on undercarboxylated and intact osteocalcin in osteoporotic patients with vertebral or hip fractures. Clin Endocrinol 54: 219-224.
28. Riggs BL, Melton LJ 3rd. 198 6. Involutional osteoporosis. N Engl J Med 314: 1676-1686.
29. Sadowski JA, Hood SJ, Dallal GE, Garry PJ. 1989. Phylloquinone in plasma from elderly and young adults: factors influencing its concentration. Am J Clin Nutr 50: 100-108.
30. Braam L, McKeown N, Jacques P, Lichtenstein A, Vermeer C, Wilson P, Booth S. 2004. Dietary phylloquinone intake as a potential marker for a heart-healthy dietary pattern in the Framingham Offspring cohort. J Am Diet Assoc 104: 1410-1414.
31. Schurgers LJ, Vermeer C. 2002. Differential lipoprotein transport pathways of K-vitamins in healthy subjects. Biochim Biophys Acta 1570: 27-32.
32. Geleijnse JM, Vermeer C, Grobbee DE, Schurgers LJ, Knapen MH, van der Meer IM, Hofman A, Witteman JC. 2004. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr 134: 3100-3105.